Replies to post #114723 on Biotech Values

[dewophile]

Teva’s Lovenox by 4/1/11 is quite impossible

i wouldn't say impossible - teva could respond by the end of the month and the FDA can turn around and approve a month later

[zipjet]

the more basic criticism of the report is that FDA approval of Teva’s Lovenox by 4/1/11 is quite impossible.

How can you support "impossibility"?

Your assertion makes no sense in the light of the facts.

ij

[exwannabe]

I don’t think they are applying a probably weighting in this instance, but the more basic criticism of the report is that FDA approval of Teva’s Lovenox by 4/1/11 is quite impossible. The only reason I can see for using such a date for modeling purposes is to mislead.

Not really, I often use April 1 as a date to imply I think it is nonsense.

I really can not wait till next year when we here Bill Marth state "We now are 100% certain to have a final answer from the FDA by 12/21/12"